articleTop 1% cited

High Recurrence Rates of Bacterial Vaginosis over the Course of 12 Months after Oral Metronidazole Therapy and Factors Associated with Recurrence

The Journal of Infectious Diseases · 2006 · Vol. 193(11) · pp. 1478–1486

Catriona S. Bradshaw✉(Institute of Population and Public Health)Anna N. Morton(The Alfred Hospital)Jane S. Hocking(Institute of Population and Public Health)Suzanne M. Garland(Royal Women's Hospital)Michael B. Morris(Melbourne Sexual Health Centre)Lorna M. Moss(Melbourne Sexual Health Centre)Leonie B. Horvath(University of Melbourne)Irene Kuzevska(Melbourne Sexual Health Centre)Christopher K. Fairley(The Alfred Hospital)

View via DOI Publisher page

Abstract

Current recommended treatment is not preventing the recurrence of BV or abnormal vaginal flora in the majority of women; factors associated with recurrence support a possible role for sexual transmission in the pathogenesis of recurrent BV.

Reproductive tract infections research Syphilis Diagnosis and Treatment Clostridium difficile and Clostridium perfringens researchBacterial vaginosisVaginal floraMedicineMetronidazoleConfidence intervalSexual transmissionVaginaInternal medicineGynecologySurgery

MeSH terms

AdultContraceptives, Oral, HormonalFemaleHumansMetronidazoleMiddle AgedSurveys and QuestionnairesRecurrenceRisk FactorsSeverity of Illness IndexSexual BehaviorTime FactorsVaginaIncidenceMultivariate Analysis

Citations

756

FWCI

11.36

field-weighted impact

References

Percentile

99%

vs. same field & year

Citations per year

Cited by

Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis